Solana Company Expresses Confidence as Investors Gain Right to Resell Shares

Solana (NASDAQ: HSDT), formerly known as Helius Medical Technologies, announced that it is going on the offensive by opening a resale opportunity for private investors — a move that could test confidence in its new digital asset treasury linked to the Solana blockchain.

On Monday, the company completed the registration of a resale offering, granting investors who participated in a private placement the right to sell shares tied to its digital asset treasury.

The company filed with regulators to unlock previously restricted shares issued during its September funding round, allowing early investors to offload their holdings, which in turn triggered a sharp selloff in HSDT shares.

“We are playing the long game and invite you to join us. We are on the attack, not on defense. Thank you for your trust and partnership,” said Joseph Chi, Executive Chairman of Solana Company, in a statement.

According to Nasdaq data, HSDT opened at $8.92 and closed at $6.87 on Monday, marking a 22% intraday decline after private investors gained the right to resell their shares.

The company’s market value has fallen roughly 60% over the past week, while daily trading volume surged from under 1 million shares on October 15 to about 4.6 million shares by Monday.

Company executives said that opening the resale window now, rather than waiting for a calmer market period, reflects confidence in the firm’s long-term strategy and its commitment to transparency.

“Markets can be volatile, and companies managing digital assets will continue to face fluctuations in the broader macroeconomic environment,” Chi added.

The same resale registration statement detailed how Solana raised approximately $500 million in mid-September through two private placements — one funded in cash and the other in Solana (SOL) tokens, backed by investors such as Pantera Capital and Summer Capital.

The proceeds were used to accumulate SOL as part of the company’s new digital asset management strategy, while the registration enables private investors to sell their shares on the open market following approval by the U.S. Securities and Exchange Commission (SEC).

Before its transition to Solana, Helius specialized in medical device manufacturing. As of early October, Solana Company ranked second among firms holding publicly traded Solana treasury tokens, totaling 2.2 million SOL.

Solana Company’s approach combines staking-based yield, strategic accumulation of SOL during market downturns, and a regulated financial structure that provides institutional access to Solana-linked assets. This setup effectively shifts price discovery from token holders to equity investors.

Unlike earlier corporate Bitcoin treasury models, this structure directly links Solana’s performance to the company’s shares, concentrating both returns and risks within a single market instrument.

“When the nonbelievers leave, HSDT will continue to grow its per-share Solana exposure. We can buy aggressively when others are fearful,” Chi wrote.
“We believe we can increase Solana exposure per share through disciplined capital allocation.”

See also: "Gold Sets New Price Record and Surpasses Bitcoin in Returns"

#Solana (SOL)

Share: